Search
EMA OPEN Framework 2026 Update: What Pharma and Regulatory Affairs Teams Need to Know
The EMA OPEN framework (Opening Procedures at EMA to Non-EU Authorities) allows the European Medicines Agency (EMA) to run near-concurrent scientific assessments of certain medicines alongside seven non-EU regulatory partners, while each authority keeps full independence over its own decision. Originally piloted for COVID-19 medicines in December 2020, it was expanded to a wider range of therapeutic areas on 20 July 2023 and remains the operational basis for cross-border coll
Aug 511 min read
From Hospital Pharmacy to the MHRA: How Jas Changed Her Career in Regulatory Affairs
Part of the Entry to Regulatory Success Stories Series Jas was a hospital pharmacist who felt stuck — until she discovered regulatory affairs. Here's how she made the leap to the MHRA, and what her journey can teach you. She Knew Medicines Inside Out. But the Industry Didn't Know Her. Jas had built her career in hospital pharmacy. Day after day, she worked at the intersection of medicines, patients, and clinical decision-making — reviewing prescriptions, counselling patie
Jun 198 min read